北京万东医疗科技股份有限公司关于股份回购进展的公告

Group 1 - The company has approved a share repurchase plan using its own funds, with a total amount ranging from RMB 30 million to 60 million, and a maximum repurchase price of RMB 25 per share, to be implemented within 12 months [1] - As of October 9, 2025, the company has repurchased a total of 281,200 shares, representing 0.04% of the total share capital, with a total expenditure of RMB 4,998,291, excluding transaction fees [2] - The company will continue to make repurchase decisions based on market conditions and will fulfill its information disclosure obligations in a timely manner [3]